Cerity Partners LLC Buys 1,590 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Cerity Partners LLC increased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 9.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 17,589 shares of the exchange traded fund’s stock after acquiring an additional 1,590 shares during the period. Cerity Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $1,604,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. FMR LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 13.6% in the third quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock valued at $686,000 after purchasing an additional 830 shares in the last quarter. Ameritas Advisory Services LLC raised its position in SPDR S&P Biotech ETF by 11.9% in the 4th quarter. Ameritas Advisory Services LLC now owns 10,684 shares of the exchange traded fund’s stock valued at $962,000 after buying an additional 1,137 shares during the last quarter. Van ECK Associates Corp bought a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at approximately $1,497,000. Parallel Advisors LLC boosted its position in SPDR S&P Biotech ETF by 3.8% during the 4th quarter. Parallel Advisors LLC now owns 42,574 shares of the exchange traded fund’s stock worth $3,834,000 after acquiring an additional 1,568 shares during the last quarter. Finally, Quantbot Technologies LP grew its stake in shares of SPDR S&P Biotech ETF by 31.8% during the 4th quarter. Quantbot Technologies LP now owns 48,294 shares of the exchange traded fund’s stock worth $4,349,000 after acquiring an additional 11,663 shares in the last quarter.

SPDR S&P Biotech ETF Stock Down 1.8 %

Shares of XBI stock opened at $75.13 on Thursday. The firm has a market cap of $4.74 billion, a PE ratio of 11.47 and a beta of 1.00. SPDR S&P Biotech ETF has a 12 month low of $66.66 and a 12 month high of $105.47. The company’s fifty day simple moving average is $84.31 and its 200-day simple moving average is $91.47.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.